Ikarian Capital, LLC Biotechnology

Ikarian Capital, LLC

  • $328 Million
  • Q2 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
RARE
Ultragenyx Pharmaceutical Inc.
CALL
$20.5 Million
563K
Q1 2025
Added 21.23%
CAPR
Capricor Therapeutics, Inc.
PUT
$13.5 Million
1.36M
Q3 2024
New holding
RARE
Ultragenyx Pharmaceutical Inc.
PUT
$10.9 Million
300K
Q1 2025
Added 21.23%
VKTX
Viking Therapeutics, Inc.
CALL
$9.28 Million
350K
Q2 2025
Added 100.0%
MLTX
Moon Lake Immunotherapeutics
PUT
$9.18 Million
195K N/A
CAPR
Capricor Therapeutics, Inc.
CALL
$6.95 Million
700K
Q3 2024
New holding
SRPT
Sarepta Therapeutics, Inc.
CALL
$5.68 Million
332K
Q2 2025
Added 165.6%
CYTK
Cytokinetics Inc
CALL
$4.96 Million
150K
Q2 2025
Added 55.66%
KALV
Kal Vista Pharmaceuticals, Inc.
CALL
$4.52 Million
400K
Q2 2025
New holding
MLTX
Moon Lake Immunotherapeutics
CALL
$4.46 Million
94.5K N/A
VERA
Vera Therapeutics, Inc.
CALL
$3.61 Million
153K
Q2 2025
New holding
SRRK
Scholar Rock Holding Corp
CALL
$3.54 Million
100K
Q2 2025
Reduced 79.86%
ALT
Altimmune, Inc.
CALL
$3.2 Million
828K
Q1 2023
Added 147.7%
CNTA
Centessa Pharmaceuticals PLC
CALL
$2.63 Million
200K N/A
AKRO
Akero Therapeutics, Inc.
CALL
$2.37 Million
44.4K
Q2 2025
Reduced 10.2%
COGT
Cogent Biosciences, Inc.
CALL
$1.89 Million
263K
Q2 2025
New holding
PRTA
Prothena Corp Public LTD CO
CALL
$607,000
100K
Q2 2021
Closed
KYMR
Kymera Therapeutics, Inc.
PUT
$436,000
10K
Q2 2022
Closed
PCVX
Vaxcyte, Inc.
CALL
$224,000
6.9K
Q2 2025
Added 52.5%
Filter Shares Options
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email